HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines.

Abstract
SN-38 (7-ethyl-10-hydroxycamptothecin) is the active metabolite of irinotecan, which is 100-to 1000-fold more cytotoxic than irinotecan. Nevertheless, extreme hydrophobicity of SN-38 has prevented its clinical use. One way of improving the solubility and stability of SN-38 is to formulate the drug into nanoparticles. Folic acid has been widely used as a targeting moiety for various anticancer drugs. For folate-receptor-targeted anticancer therapy, SN-38 nanoparticles were produced using poly-lactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate by emulsification/solvent evaporation method. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH(2) di-block copolymer with an activated folic acid. The conjugates were used for the formation of SN-38 nanoparticles with an average size of 200 nm in diameter. The SN-38 targeted nanoparticles showed a greater cytotoxicity against HT-29 cancer cells than SN-38 nontargeted nanoparticles. These results suggested that folate-targeted nanoparticles could be a potentially useful delivery system for SN-38 as an anticancer agent.
FROM THE CLINICAL EDITOR:
SN-38 is the active metabolite of the chemotherapy agent irinotecan, which is 100-1000 fold more cytotoxic than irinotecan, but its extreme hydrophobicity has prevented its clinical use. In this paper, the authors present a nanotechnology-based approach targeting the folate-receptor with SN-38 loaded nanoparticles, demonstrating stronger cytotoxicity against HT-29 cancer cells than with control nanoparticles.
AuthorsPedram Ebrahimnejad, Rassoul Dinarvand, Abolghasem Sajadi, Mahmoud Reza Jaafari, Ali Reza Nomani, Ebrahim Azizi, Mazda Rad-Malekshahi, Fatemeh Atyabi
JournalNanomedicine : nanotechnology, biology, and medicine (Nanomedicine) Vol. 6 Issue 3 Pg. 478-85 (Jun 2010) ISSN: 1549-9642 [Electronic] United States
PMID19836467 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Buffers
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Polyethylene Glycols
  • Irinotecan
  • Folic Acid
  • Camptothecin
Topics
  • Buffers
  • Camptothecin (analogs & derivatives, chemistry, pharmacology)
  • Cell Death (drug effects)
  • Drug Delivery Systems (methods)
  • Folic Acid (chemistry)
  • HT29 Cells
  • Humans
  • Irinotecan
  • Lactic Acid (chemistry)
  • Microscopy, Fluorescence
  • Nanoparticles (chemistry, ultrastructure)
  • Polyethylene Glycols (chemistry)
  • Polyglycolic Acid (chemistry)
  • Polylactic Acid-Polyglycolic Acid Copolymer

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: